U.S. Beverage Stock News

NYSE:COP
NYSE:COPOil and Gas

ConocoPhillips Permian Sale Review Highlights Portfolio High Grading And Cash Goals

ConocoPhillips (NYSE:COP) is reportedly weighing the sale of certain Permian Basin assets in a potential US$2b transaction. The assets under review sit within one of the most active US shale regions, drawing interest from both industry buyers and private equity firms. The move is described as part of a broader effort by the company to streamline its portfolio and adjust its asset mix. For you as an investor, the Permian sits at the heart of US shale oil and gas activity, and ConocoPhillips...
NasdaqGS:SHOO
NasdaqGS:SHOOLuxury

Steven Madden Q4 Beat Highlights Brand Strength But Tariff And Margin Strain

Steven Madden (NasdaqGS:SHOO) reported Q4 2025 results that came in above its prior guidance. The quarter featured strong performance in its core footwear business and the recently acquired Kurt Geiger brand. The company recorded an impairment on intangible assets related to its portfolio. Management cited ongoing U.S. tariff policy challenges and chose not to issue earnings guidance for 2026. Steven Madden, a well known name in branded footwear and accessories, sits at the intersection of...
NYSE:JBL
NYSE:JBLElectronic

Jabil Faces New Tariff Headwinds As Strong Run Meets Valuation Cushion

The US administration has imposed a new 15% global tariff under the Trade Act of 1974. This policy affects companies with extensive international supply chains, including Jabil (NYSE:JBL). The tariff change introduces new uncertainty for Jabil’s cost structure and cross border operations. Jabil, trading at $264.99, has been closely tied to global manufacturing and complex supply chains, so a broad 15% tariff directly touches the core of how it does business. The stock has shown strong...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

Is Bentley Systems (BSY) Share Price Slide Creating A Potential Opportunity Today

If you are wondering whether Bentley Systems' current share price lines up with its underlying worth, this article will walk through what the numbers say and where valuation questions remain open. The stock last closed at US$36.56, with returns of 8.0% over the past 7 days, a 2.1% decline over 30 days, a 4.2% decline year to date, and a 16.2% decline over the past year, along with a 12.7% decline over 3 years and a 20.9% decline over 5 years. Recent coverage of Bentley Systems has focused on...
NasdaqGM:APGE
NasdaqGM:APGEBiotechs

A Look At Apogee Therapeutics (APGE) Valuation As Great Point Partners Lifts Its Stake

Great Point Partners has increased its exposure to Apogee Therapeutics (APGE), with filings showing the fund now holds about 9.15% of its assets in the company, alongside advancing atopic dermatitis and asthma programs. See our latest analysis for Apogee Therapeutics. Apogee’s latest US$70.05 share price comes after a mixed few months, with a slightly negative 90 day share price return but a very strong 1 year total shareholder return of about 123%, as investors focus on upcoming trial...
NYSE:COMP
NYSE:COMPReal Estate

Is Compass (COMP) Now Attractively Priced After The Recent 24.6% Share Price Decline?

If you are wondering whether Compass at around US$9.84 is priced fairly or offering value, you are not alone. This article is built to help you make sense of that question. The share price has seen a 24.6% decline over the last 30 days, even though the 1 year return sits at 9.4% and the 3 year return is very large. Recent coverage has focused on Compass as a real estate platform operator, with investors watching how its model responds to shifts in housing activity and transaction volumes...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Stronger Margins, Bookings and Guidance Might Change The Case For Investing In MACOM (MTSI)

Earlier this week, MACOM Technology Solutions Holdings reported quarterly results that were in line with expectations, highlighted by sequential gross margin improvement, strong year-on-year revenue growth and one of its strongest booking quarters in years, alongside guidance for the next quarter that exceeded analyst forecasts. Management emphasized that robust demand across data infrastructure, satellite communications and industrial applications is aligning with its focus on higher-value...
NYSE:BK
NYSE:BKCapital Markets

Bank Of New York Mellon Capital Move Tests Valuation And Dividend Appeal

Bank of New York Mellon Corporation (NYSE:BK) completed a $500 million preferred stock offering of Series M Noncumulative Perpetual Preferred Stock via depositary shares. The company indicated that proceeds may be used to redeem outstanding Series F Preferred Stock and potentially Series H Preferred Stock. For investors watching BNY, the preferred stock move comes with the common share price at $118.8 and a value score of 3. The stock has returned 36.4% over the past year and 151.5% over 3...
NYSE:MAIN
NYSE:MAINCapital Markets

Main Street Capital (MAIN) One Off Gain Clouds Earnings Narratives After FY 2025 Results

Main Street Capital (MAIN) has wrapped up FY 2025 with fourth quarter revenue of US$145.5 million and EPS of US$1.46. Trailing 12 month figures sit at US$566.4 million of revenue and EPS of US$5.52, setting a clear baseline for how the business is currently earning its keep. The company has seen quarterly revenue range from US$137.0 million to US$145.5 million through 2025, with EPS moving between US$1.31 and US$1.46, and trailing 12 month net income holding in the US$493.4 million area. This...
NasdaqCM:CBIO
NasdaqCM:CBIOBiotechs

Crescent Biopharma (CBIO) Posts US$10.8m Q4 Revenue Against Heavy Losses Challenging Bullish Narratives

Crescent Biopharma (CBIO) closed out FY 2025 with Q4 revenue of US$10.8 million, basic EPS of a US$3.35 loss, and a net loss of US$92.4 million. Its trailing twelve month revenue was US$10.8 million, with basic EPS of a US$5.59 loss and a total net loss of US$153.9 million. The company’s quarterly revenue moved from US$0 in the first three quarters of FY 2025 to US$10.8 million in Q4. Over the same period, quarterly basic EPS moved from a US$18.39 loss in Q1 to a US$4.93 loss in Q2, a US$1.27...
NYSE:MSGS
NYSE:MSGSEntertainment

Will a Knicks and Rangers Spin Off Reshape Madison Square Garden Sports' MSGS Core Investment Narrative

In February 2026, Madison Square Garden Sports Corp. announced that Chief Financial Officer, Executive Vice President and Treasurer Victoria Mink will depart after assisting with a potential spin-off and leadership transition. The board is exploring separating the New York Knicks and New York Rangers into two standalone public companies, a move that could reshape how investors assess each franchise’s assets, risks and opportunities. Now we’ll examine how the potential Knicks–Rangers spin-off...
NYSE:FSS
NYSE:FSSMachinery

Is It Too Late To Consider Federal Signal (FSS) After Its Strong Multi Year Rally

If you are looking at Federal Signal and wondering whether the recent share price puts it at a fair level or not, this article walks through what the current market price might be implying about value. The stock last closed at US$116.43, with a 1.9% decline over the past 7 days, a 6.8% gain over 30 days, a 4.5% return year to date, 44.1% over 1 year, 110.5% over 3 years, and 225.3% over 5 years. Recent news around Federal Signal has largely focused on its position in specialized vehicles and...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Ulta Beauty Weighs Global Growth Inclusivity And AI Against Premium Valuation

Ulta Beauty, NasdaqGS:ULTA, is advancing a global expansion plan under new CEO Kecia Steelman. The company is widening support for women and BIPOC owned brands through its MUSE Accelerator program. Ulta is rolling out AI driven personalization tools to refine customer engagement and product discovery. Ulta Beauty enters this phase of change with its shares at $684.79 and multi year returns that some investors may find meaningful, including 105.4% over 5 years and 86.9% over 1 year. Over...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital (NasdaqGS:GLXY) Valuation Check After Sharp Short Term Declines And Strong Longer Term Returns

Galaxy Digital overview Galaxy Digital (GLXY) has been drawing attention after recent share price moves, with returns over the past month and the past 3 months turning negative even as its 1 year total return remains positive. See our latest analysis for Galaxy Digital. The recent 35.45% 1 month share price decline and 22.56% 3 month share price decline contrasts with Galaxy Digital’s very large 3 year total shareholder return. This suggests momentum has cooled even as longer term holders...
NYSE:ACA
NYSE:ACAConstruction

Arcosa (ACA) Margin Expansion Reinforces Bullish Narratives Despite Slower Revenue Forecasts

Arcosa (ACA) books higher FY 2025 earnings with wider margins Arcosa (ACA) has capped FY 2025 with fourth quarter revenue of US$716.7 million and basic EPS of US$1.06, rounding out a year where trailing twelve month EPS reached US$4.26 on revenue of US$2.88 billion and net income of US$208.4 million. The company reported a current net margin of 7.2% compared with 3.6% a year earlier. Over recent quarters the company has seen revenue move from US$632 million in Q1 2025 to US$716.7 million in...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

JetBlue Engine Fire Puts Safety Response And Investor Sentiment Under Scrutiny

A JetBlue flight experienced a loud boom and engine fire mid air, triggering an emergency landing and evacuation via emergency slides. All passengers were safely deplaned, and the airline provided refunds and travel vouchers following the incident. Some travelers reported difficulties redeeming the issued vouchers, raising questions around JetBlue's customer response. For investors watching NasdaqGS:JBLU, this incident sits at the intersection of airline operations, safety protocols, and...
NasdaqGS:MGPI
NasdaqGS:MGPIBeverage

MGP Ingredients (MGPI) Is Down 26.8% After Major Impairment And 2026 Sales Guidance Cut - Has The Bull Case Changed?

MGP Ingredients, Inc. has reported past fourth-quarter 2025 results showing sales of US$138.32 million and a net loss of US$134.63 million, driven largely by a very large US$152.62 million goodwill and intangible asset impairment in its Branded Spirits segment. For 2025 as a whole, the company moved from net income to a net loss, while simultaneously closing a US$117.17 million common stock shelf registration, maintaining a quarterly dividend of US$0.12 per share, and issuing 2026 sales...
NasdaqGM:TKNO
NasdaqGM:TKNOLife Sciences

Alpha Teknova (TKNO) Q4 Loss Highlights Ongoing Profitability Concerns Despite Bullish DCF Narrative

Alpha Teknova (TKNO) just wrapped up FY 2025 with Q4 revenue of US$10.0 million, a basic EPS loss of US$0.09 per share, and trailing twelve month revenue of US$40.5 million alongside a TTM basic EPS loss of US$0.32. The company reported quarterly revenue moving from US$9.3 million in Q4 2024 to US$10.5 million in Q3 2025, while quarterly basic EPS losses ranged between US$0.07 and US$0.15 over that period. These latest numbers keep the focus on how quickly margins may tighten and losses may...
NYSE:BCO
NYSE:BCOCommercial Services

Brink’s (BCO) EPS Surge Versus 5.1% Revenue Growth Tests Bullish Margin Narrative

Brink's (BCO) closed out FY 2025 with fourth quarter revenue of US$1.4b and basic EPS of US$1.64, alongside net income from continuing operations of US$68.4m. Over recent periods the company has seen quarterly revenue move from US$1.26b in Q3 2024 to US$1.25b in Q2 2024, then to US$1.25b in Q1 2025 and on to US$1.38b in Q4 2025, while basic EPS shifted from US$0.65 to US$1.04, then US$1.20 and up to US$1.64 over the same span. With trailing twelve month net margin improving and earnings...
NYSE:TAP
NYSE:TAPBeverage

Is Molson Coors (TAP) Pricing Reflect Its Mixed Returns And Brand Positioning Shifts

If you are wondering whether Molson Coors Beverage is fairly priced or offering value right now, you are not alone. This article will walk you through what the numbers are actually saying. The stock closed at US$48.99, with returns of 1.7% decline over the past 7 days, 2.6% over 30 days, 3.4% year to date, 17.7% decline over 1 year, 0.0% over 3 years, and 21.9% over 5 years, which gives a mixed picture of how the market has recently treated the shares. Recent news around the company has...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

Progyny (PGNY) Margins Hold At 4.5% Questioning Bullish Earnings Expansion Narratives

Progyny (PGNY) has just posted its FY 2025 numbers, with fourth quarter revenue of US$318.4 million and basic EPS of US$0.15, alongside trailing twelve month revenue of about US$1.3 billion and basic EPS of US$0.68. Over the past few quarters, revenue has ranged from US$313.3 million to US$332.9 million with basic EPS moving between US$0.15 and US$0.20, while trailing net income excluding extra items sits at US$58.5 million across the last year. For investors, the headline story focuses on...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

Reassessing AtriCure (ATRC) After Prolonged Share Price Weakness

If you are looking at AtriCure and wondering whether the current share price reflects its true worth, you are not alone. Many investors are asking the same question right now. The stock recently closed at US$31.25, with returns of a 4.1% decline over 7 days, a 17.3% decline over 30 days and a 20.4% decline year to date, adding to a 19.3% decline over 1 year, a 21.7% decline over 3 years and a 51.0% decline over 5 years. These moves have put more attention on how AtriCure is being valued,...
NYSE:CVSA
NYSE:CVSAConsumer Services

A Look At Covista (CVSA) Valuation After Investor Day Rebrand And Healthcare Education Pivot

Covista (CVSA) stock is back in focus after the company used its Investor Day to relaunch under a new name, outline its Purpose at Scale plan, and reaffirm multi year revenue guidance through 2029. See our latest analysis for Covista. Despite the Investor Day updates and long term guidance, Covista’s recent 30 day share price return of a 15.39% decline has taken some heat out of the stock, even as its 3 year total shareholder return of 149.06% and 5 year total shareholder return of 152.78%...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

A Look At WaFd (WAFD) Valuation After Recent Share Price Pullback

WaFd stock at a glance WaFd (WAFD) shares have been under pressure recently, with a 1 day return of about a 4.4% decline and negative moves over the past week and month as investors reassess regional bank exposure. See our latest analysis for WaFd. That recent 4.4% 1 day share price decline and softer 7 day and 30 day share price returns sit against a more resilient picture, with WaFd posting a 1 year total shareholder return of 9.1% and positive results over 3 and 5 years. This suggests...